Testing an Experimental Coronavirus Vaccine

March 2, 2020

Testing an Experimental Coronavirus Vaccine

An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna is ready to enter human testing, announced NIAID director Anthony Fauci. This rapid response, getting a vaccine into phase I trials within three months of the sequencing of the virus, is a new record. Yourway has extensive experience in supporting accelerated clinical trials when the need is acute.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?